Concepedia

Andrea V. Lopez

AV

Statistics

Publications

8

Citations

819

H-Index

8

Active since

2019

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Piedmont Cancer Institute

Emory University

Kettering University

Andrea V. Lopez is an author at Memorial Sloan Kettering Cancer Center specializing in immunotherapy, life sciences, and cancer immunotherapy.

ORCID

Publications per year

2019–2023

8

Publications

8

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

Nicholas F. Kuhn, Terence J. Purdon, Dayenne G. van Leeuwen et al. · Cancer Cell · 2019 · 238 citations · Full text

, , +12

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Andrea V. Lopez, Khong Y. Ng et al. · Blood Cancer Discovery · 2020 · 214 citations · Full text

, , +17

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models

Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey et al. · Journal of Clinical Investigation · 2023 · 170 citations · Full text

, , +17

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Xinghuo Li, Anthony F. Daniyan, Andrea V. Lopez et al. · Leukemia · 2020 · 65 citations · Full text

, , +16

CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li et al. · Nature Communications · 2020 · 48 citations · Full text

, , +17

1–5 of 8